Vyvanse (2015-12-23)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
| Lot or serial number | Brand name | Companies | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| AD8671B | Vyvanse | - Recalling Firm
- Shire Pharma Canada ULC
- 2250 Alfred-Nobel Blvd, suite 500
- Saint-Laurent
- H4S 2C9
- Quebec
- CANADA
- Marketing Authorization Holder
- Shire Pharma Canada ULC
- 2250 Alfred-Nobel Blvd, suite 500
- Saint-Laurent
- H4S 2C9
- Quebec
- CANADA
| Capsule | DIN 02322951 | Lisdexamfetamine Dimesylate 30mg |
Affected Products
Vyvanse
Some labels were found missing on product bottles from these lots.
Wholesalers across Canada